This study from the Johns Hopkins Scleroderma Center found that scleroderma patients with multiple autoimmune responses may be protected from the development of cancer.
Multiple Autoimmune Responses in Scleroderma May Protect Against Cancer
News
Leap – Winter 2019: Seen for the First Time
Alice in Wonderland may come to mind as you read this issue of LEAP, because we are moving from the large to the small, and back again: A rheumatic disease is big, and its effect can be devastating. However, a disease such as rheumatoid arthritis, scleroderma, or Sjögren’s is, in fact, multiple diseases, each slightly different.
Automated Detection of Erythema Migrans in early Lyme disease, and Other Confounding Skin Lesions, via Deep Learning
Summary The study shows that deep machine learning can be utilized to more accurately identify erythema migrans rashes in early Lyme disease. Recognition of the EM rash is crucial to […]
PET Imaging of Glial Activation in Patients with Post Treatment Lyme Disease
This study uses a neuroimaging radiotracer with positron emission tomography (PET) to quantify cerebral glial activation in brains of patients with post-treatment Lyme disease. Results show elevated central nervous system immune activation in patients with PTLDS as compared to controls.
Myositis Patients, Caregivers, and Healthcare Providers Weigh-in About What is Most Important to Them
Our results indicate that substantial differences exist in how myositis is perceived by patients compared to healthcare providers, with different items prioritized.
Dermatomyositis Autoantibodies associated with adverse skin reactions after treatment
Hydroxychloroquine sulfate is frequently used to treat patients with dermatomyositis. It has been associated with an increased risk of adverse skin reactions in these patients.
